This is a StreetInsider.com Premium Only Page

Harmony Biosciences (HRMY) – StreetInsider.com Reports

Apr 11, 2024 08:37 AM Harmony Biosciences (HRMY) Enters into a License Agreement with Bioprojet

Apr 3, 2024 08:05 AM Harmony Biosciences (HRMY) Commences Phase 3 TEMPO Study

Feb 27, 2024 06:38 AM Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $40 at Mizuho Securities

Feb 23, 2024 07:33 AM Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $50 at Needham & Company

Feb 22, 2024 12:00 PM Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $34 at Raymond James

Feb 22, 2024 07:36 AM Harmony Biosciences (HRMY) Tops Q4 EPS by 1c

Feb 21, 2024 08:06 AM Harmony Biosciences (HRMY) Announces FDA Grants Priority Review for Application For Wakix (Pitolisant) In Pediatric Narcolepsy

Feb 20, 2024 08:05 AM Harmony Biosciences (HRMY) Receives U.S. Food And Drug Administration Orphan Drug Designation For Pitolisant In Prader-willi Syndrome

Feb 15, 2024 06:26 AM Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $42 at Mizuho Securities

Jan 9, 2024 05:59 AM Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $28 at Goldman Sachs

Jan 8, 2024 08:17 AM Harmony Biosciences (HRMY) Preliminary Unaudited Fourth Quarter And Full Year 2023 Net Product Revenue Increases

Jan 2, 2024 05:24 AM BofA Securities Downgrades Harmony Biosciences Holdings Inc. (HRMY) to Underperform, 'lack of catalysts + limited valuation upside'

Dec 7, 2023 08:06 AM Harmony Biosciences (HRMY) Announces Positive Topline Data From Phase 2 Signal Detection Study Evaluating Pitolisant In Adult Patients With Myotonic Dystrophy Type 1

Nov 8, 2023 08:05 AM Harmony Biosciences (HRMY) Appoints Peter Anastasiou to its Board

Nov 6, 2023 06:34 AM Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $33 at Mizuho Securities

Nov 3, 2023 12:57 PM Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $33 at Mizuho Securities

Oct 31, 2023 08:05 AM Harmony Biosciences (HRMY) Tops Q3 EPS by 30c

Oct 19, 2023 06:36 AM Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $28 at Mizuho Securities

Oct 16, 2023 09:50 AM Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $27 at BofA Securities

Oct 16, 2023 07:18 AM Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $53 at Needham & Company

Oct 16, 2023 06:36 AM Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $49 at Cantor Fitzgerald

Oct 16, 2023 06:00 AM Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $25 at Goldman Sachs

Oct 13, 2023 12:20 PM Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $26 at Raymond James

Oct 13, 2023 08:13 AM Harmony Biosciences (HRMY) Falls 14% Following Data From Phase 3 Intune Study of pitolisant in IH

Oct 13, 2023 08:01 AM Harmony Biosciences (HRMY) Reports Topline Data from Phase 3 Intune Study of pitolisant

Oct 11, 2023 08:02 AM Harmony Biosciences (HRMY) Competes Acquisition of Zynerba Pharmaceuticals

Oct 5, 2023 08:05 AM Harmony Biosciences (HRMY) Presents New Secondary Data from Phase 2 signal-detection study of pitolisant

Sep 25, 2023 07:58 AM Amazon, Warner Bros, and Dow rise premarket; Nio, Nike, HP fall

Sep 25, 2023 04:59 AM Goldman Sachs Downgrades Harmony Biosciences Holdings Inc. (HRMY) to Sell, 'Risks to out-year revenue emerging'

Sep 7, 2023 08:07 AM Harmony Biosciences (HRMY) Granted FDA Orphan Drug Designation for pitolisant

Sep 7, 2023 04:41 AM Berenberg Starts Harmony Biosciences Holdings Inc. (HRMY) at Buy, 'de-risked story that is currently trading near the low end of its 52-week range'

Aug 28, 2023 08:01 AM Harmony Biosciences (HRMY) Reiterates Confidence in WAKIX Patens

Aug 14, 2023 07:31 AM Zynerba Pharma (ZYNE) Acquired by Harmony Biosciences (HRMY) for $1.1059/sh plus CVR

Aug 3, 2023 06:39 AM Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $54 at Mizuho Securities

Aug 2, 2023 08:07 AM Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $71 at Cantor Fitzgerald

Aug 1, 2023 07:34 AM Harmony Biosciences (HRMY) Tops Q2 EPS by 15c

Aug 1, 2023 07:21 AM Harmony Biosciences (HRMY) Announces $125M Share Buyback

Jul 27, 2023 08:06 AM Harmony Biosciences (HRMY) Enters $185M Term Loan Facility

Jul 20, 2023 08:06 AM Harmony Biosciences (HRMY) to Initiate Phase 3 Study of pitolisant in Prader-Willi syndrome

Jun 7, 2023 04:10 PM Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $38 at Goldman Sachs

Jun 6, 2023 08:06 AM Harmony Biosciences (HRMY) Reports Positive Phase 2 Signal Detection Study Data

May 3, 2023 06:42 AM Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $75 at Cantor Fitzgerald

May 2, 2023 07:41 AM Harmony Biosciences (HRMY) Tops Q1 EPS by 18c

Apr 24, 2023 08:08 AM Harmony Biosciences (HRMY) Appoints Jeffrey M. Dayno as President and CEO

Apr 20, 2023 06:05 AM BofA Securities Starts Harmony Biosciences Holdings Inc. (HRMY) at Neutral

Mar 29, 2023 08:05 AM Harmony Biosciences (HRMY) Announces Accelerated Timeline for Phase 3 INTUNE Trial

Mar 28, 2023 01:04 PM Raymond James Defending Harmony Biosciences (HRMY)

Mar 28, 2023 09:56 AM Harmony Biosciences (HRMY) plunges following Scorpion Capital short report

Mar 28, 2023 09:04 AM Harmony Biosciences (HRMY) Mentioned Cautiously by Short Seller Scorpion Capital

Feb 22, 2023 07:29 AM Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $67 at Needham & Company